SIGCIFITI
Live / Allowed — Published for opposition (as of 27 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99698341
- Mark type
- Word mark
- Filed
- 12 Mar 2026
- Published for opposition
- 27 Oct 2026
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 27 Oct 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Oct 2026 — PUBLISHED FOR OPPOSITION
- 21 Oct 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Sept 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 03 Sept 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 03 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jun 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 22 Jun 2026 — LETTER OF SUSPENSION E-MAILED
- 22 Jun 2026 — SUSPENSION LETTER WRITTEN
- 18 Jun 2026 — ASSIGNED TO EXAMINER